Last updated: about 1 month ago
AstraZeneca's Tezspire Gains EU Approval for CRSwNP: A Game-Changer in Treatment
AstraZeneca's Tezspire is now approved in the EU for chronic rhinosinusitis with nasal polyps, addressing unmet medical needs. Significant trial results highlight its efficacy.